Sandra Eloranta | Karolinska Institutet

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Jag är matematisk statistiker och docent i klinisk epidemiologi med lång erfarenhet av populationsbaserad cancerforskning. Mina huvudsakliga
forskningsintressen är statistiska och epidemiologiska metoder som används för att studera populations-baserad cancerpatientöverlevnad samt frågor som rör överlevarskap efter lymfom. Jag arbetar till vardags i cancerepidemiologigruppen på avdelningen för klinisk epidemiologi vid
institutionen för medicin, Solna. En närmare presentation av min aktuella forskning finns på min engelska sida [1].
[1] https://staff.ki.se/people/sandra-eloranta

Artiklar

Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2024;113(5):641-650
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study
Jorgensen RRK; Jakobsen LH; Eloranta S; Smedby KE; Pedersen RS; Jorgensen JM; Clausen MR; Brown P; Gang AO; Gade I-L; Larsen TS; Jerkeman M; El-Galaly TC
Article: HEALTH INFORMATICS JOURNAL. 2024;30(4):14604582241290725
Smart variant filtering - A blueprint solution for massively parallel sequencing-based variant analysis
Brahimllari O; Eloranta S; Georgii-Hemming P; Haider Z; Koch S; Krstic A; Skarp FP; Rosenquist R; Smedby KE; Taylan F; Thorvaldsdottir B; Wirta V; Wasterlid T; Boman M
Article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2024;50(12):108673
Survival after surgery beyond total mesorectal excision for primary locally advanced rectal cancer, a population-based study.
Bolmstrand B; Nilsson PJ; Eloranta S; Martling A; Buchli C; Palmer G
Article: ACTA ONCOLOGICA. 2024;63:563-572
The National Swedish Lymphoma Register - a systematic validation of data quality
Smedby KE; Eloranta S; Wasterlid T; Falini V; Jerlstrom U; Ellin F; Papworth K; Westerberg J; Lewerin C; Andersson P-O; Kristjansdottir HL; Brandefors L; Morth C-L; Hallen K; Kuric N; Abu Sabaa A; Wahlin BE; Molin D; Enblad G; Horsted A-S; Jerkeman M; Glimelius I
Article: JOURNAL OF SLEEP RESEARCH. 2024;:e14267
Trends in hypnotic drug use in depression 2007-2017: A Swedish population-based study
Nygren A; Brenner P; Brandt L; Karlsson P; Eloranta S; Reutfors J
Article: JCO CLINICAL CANCER INFORMATICS. 2024;8:e2300255
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Jorgensen RRK; Bergstroem F; Eloranta S; Severinsen MT; Smeland KB; Fossa A; Christensen JH; Hutchings M; Bo Dahl-Sorensen R; Kamper P; Glimelius I; Smedby K; Parsons S; Rodday AM; Maurer M; Evens A; El-Galaly T; Jakobsen LH
Article: LEUKEMIA AND LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2024;204(3):967-975
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study
Baech J; Husby S; Trab T; Kragholm K; Brown P; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Severinsen MT; Gronbaek K; Larsen TS; Wasterlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
Article: JOURNAL OF CANCER SURVIVORSHIP. 2024;:1-11
Long-term prescribed drug use in stage I-III rectal cancer patients in Sweden, with a focus on bowel-regulating drugs after surgical and oncological treatment
Boman SE; Fuentes S; Nordenvall C; Martling A; Chen L; Glimelius I; Neovius M; Smedby KE; Eloranta S
Journal article: PEERJ. 2024;12:e17841
Predicting maintenance lithium response for bipolar disorder from electronic health records-a retrospective study
Hayes JF; Ben Abdesslem F; Eloranta S; Osborn DPJ; Boman M
Article: TRANSPLANT INTERNATIONAL. 2024;37:13173
Previous Solid Organ Transplantation Influences Both Cancer Treatment and Survival Among Colorectal Cancer Patients
Benoni H; Nordenvall C; Hellstrom V; Dietrich CE; Martling A; Smedby KE; Eloranta S
Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(35):5376-5387
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY
Article: BMJ OPEN. 2023;13(12):e078023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study
Rodriguez-Wallberg KA; Nilsson HP; Bergh J; Malmros J; Ljungman P; Foukakis T; Stragliotto CL; Friman EI; Linderholm B; Valachis A; Andersson A; Harrysson S; Vennstrom L; Frisk P; Moerse H; Eloranta S
Article: EUROPEAN JOURNAL OF CANCER. 2023;195:113403
Secondary malignancies among mantle cell lymphoma patients
Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Journal article: BLOOD. 2023;142:4455
Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index ( A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients
Jorgensen RRK; Eloranta S; Christensen JH; Hutchings M; Dahl-Soerensen RB; Kamper P; Evens AM; Maurer MJ; Parsons SK; Rodday AM; Upshaw J; El-Galaly TCC; Jakobsen LH
Article: THE LANCET HAEMATOLOGY. 2023;10(10):e838-e848
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population- based, retrospective cohort study
Trab T; Baech J; Jakobsen LH; Husby S; Severinsen MT; Eloranta S; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Larsen TS; Brown P; Gronbaek K; Smedby KE; El-Galaly TC
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;153(4):723-731
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;202(4):785-795
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:475-476
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Abalo K; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:429-430
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Smedby KE; Antonilli S; Enblad G; Sonnevi K; Wahlin BE; Andersson P; Jerkeman M; Eloranta S
Article: ACTA ONCOLOGICA. 2022;61(11):1377-1385
Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study
Khoshkar Y; Vigneswaran HTT; Eloranta S; Andersson TM-L; Schain F; Boman A; Dahlkild M; Liwing J; Leval A; Akre O; Aly M
Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission
Ekberg S; Crowther M; Harrysson S; Jerkeman M; Smedby KE; Eloranta S
Journal article: HEMASPHERE. 2022;6(Suppl ):37
P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
Baech J; Jakobsen LH; El-Galaly TC; Molin D; Glimelius I; Entrop JP; Crowther MJ; Smedby KE; Eloranta S; Weibull CE
Journal article: HEMASPHERE. 2022;6(Suppl ):30
T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; øvlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
Article: BLOOD ADVANCES. 2022;6(15):4427-4435
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
Baech J; Severinsen MT; Ovlisen AK; Frederiksen H; Vestergaard P; Torp-Pedersen C; Jorgensen J; Clausen MR; Poulsen CB; Brown P; Gang AO; Pedersen RS; Smedby KE; Eloranta S; Jakobsen LH; El-Galaly TC
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Journal article: HEMASPHERE. 2022;6:103-104
S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Molin D; Glimelius I; Marklund A; Smeland KB; El‐Galaly TC; Eloranta S
Journal article: HEMASPHERE. 2022;6(Suppl):983-984
P1093: A NEW PROGNOSTIC MODEL FOR INDIVIDUAL OUTCOME PREDICTION IN ADVANCED‐STAGE HODGKIN LYMPHOMA.
Jørgensen RRK; Eloranta S; Severinsen MT; Øvlisen AK; Smeland KB; Kiserud C; Christensen JH; Hutchings M; Sørensen RB; Kamper P; Glimelius I; Smedby KE; Bergström F; El‐Galaly TC; Jakobsen LH
Journal article: HEMASPHERE. 2022;6(Suppl):1111-1112
P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH‐DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY
Trab T; Baech J; Jakobsen LH; Husby S; Severinsen MT; Eloranta S; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Larsen TS; Brown P; Smedby KE; El‐Galaly TC
Article: ACTA ONCOLOGICA. 2022;61(6):764-772
Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy
Johansson ALV; Dickman PW; Eloranta S; Bjorkholm M
Article: BLOOD ADVANCES. 2022;6(8):2657-2666
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
Joelsson J; Wasterlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
Article: BLOOD CANCER JOURNAL. 2022;12(1):16
Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark
Jakobsen LH; Ovlisen AK; Severinsen MT; Baech J; Kragholm KH; Glimelius I; Gang AO; Jorgensen JM; Frederiksen H; Poulsen CB; Clausen MR; Pedersen PT; Pedersen RS; Torp-Pedersen C; Eloranta S; El-Galaly TC
Journal article: NEUROSCIENCE APPLIED. 2022;1:100228
Trends in hypnotic drug use in depression 2007 – 2017: a Swedish population-based study
Reutfors J; Brandt L; Cabrera P; Karlsson P; Eloranta S; Brenner P
Article: FRONTIERS IN ONCOLOGY. 2022;12:984021
Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
Ruiz NR; Abd Own S; Smedby KE; Eloranta S; Koch S; Wasterlid T; Krstic A; Boman M
Article: BMJ OPEN SPORT AND EXERCISE MEDICINE. 2022;8(1):e001264
Prevalence and comorbidity of psychiatric disorders among treatment-seeking elite athletes and high-performance coaches
Akesdotter C; Kentta G; Eloranta S; Hakansson A; Franck J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(31):3463-3472
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study
Ovlisen AK; Jakobsen LH; Eloranta S; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Dahl-Sorensen RB; Stoltenberg D; Weibull CE; Entrop JP; Glimelius I; Smedby KE; Torp-Pedersen C; Severinsen MT; El-Galaly TC
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study
Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
Article: STATISTICS IN MEDICINE. 2021;40(9):2139-2154
A multistate model incorporating estimation of excess hazards and multiple time scales
Weibull CE; Lambert PC; Eloranta S; Andersson TML; Dickman PW; Crowther MJ
Article: BLOOD ADVANCES. 2021;5(6):1638-1647
Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival
Glimelius I; Smedby KE; Albertsson-Lindblad A; Crowther MJ; Eloranta S; Jerkeman M; Weibull CE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
Wasterlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
Article: LEUKEMIA. 2021;35(2):476-484
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients
Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: BLOOD CANCER JOURNAL. 2021;11(1):9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Article: JAMA ONCOLOGY. 2021;7(1):86-91
Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
Article: TRANSPLANT INTERNATIONAL. 2020;33(12):1700-1710
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Benoni H; Eloranta S; Dahle DO; Svensson MHS; Nordin A; Carstens J; Mjoen G; Helantera I; Hellstrom V; Enblad G; Pukkala E; Sorensen SS; Lempinen M; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Journal article: BLOOD. 2020;136:38-39
Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden
Smedby KE; Harrysson S; Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Eloranta S
Journal article: ANNALS OF LYMPHOMA. 2020;4(0):5
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials?
Jakobsen LH; Øvlisen AK; Eloranta S; Bøgsted M; Severinsen MT; Smedby KE; Maurer MJ; El-Galaly TC
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study
Ekberg S; Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(6):723-733
Family history of colorectal cancer and survival: a Swedish population-based study
Pesola F; Eloranta S; Martling A; Saraste D; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: HUMAN REPRODUCTION. 2020;35(4):929-938
Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)
PD10-06 REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran* HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Article: JOURNAL OF SCIENCE AND MEDICINE IN SPORT. 2020;23(4):329-335
The prevalence of mental health problems in elite athletes
Akesdotter C; Kentta G; Eloranta S; Franck J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(1):106-116
Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study
Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(2):115-121
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M; Leval A; Schain F; Liwing J; Lawson J; Vago E; Nordstrom T; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(3):682-691
Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients-A nationwide study
Benoni H; Eloranta S; Ekbom A; Wilczek H; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208
Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients
Weibull CE; Bjorkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: SMALL BUSINESS ECONOMICS. 2019;53(2):343-354
Hospitalization due to stroke and myocardial infarction in self-employed individuals and small business owners compared with paid employees in Sweden-a 5-year study
Toivanen S; Griep RH; Mellner C; Nordenmark M; Vinberg S; Eloranta S
Article: CANCER MEDICINE. 2019;8(10):4918-4927
Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark
Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; Brown PDN; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
Article: BMC PUBLIC HEALTH. 2019;19(1):495
Validation of data quality in the Swedish National Register for Breast Cancer
Lofgren L; Eloranta S; Krawiec K; Asterkvist A; Lonnqvist C; Sandelin K
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
Wasterlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte H; Bogsted M; El-Galaly TC; Smedby KE
Article: RADIOTHERAPY AND ONCOLOGY. 2019;131:229-236
Post-mastectomy radiation therapy with or without implant-based reconstruction is safe in terms of clinical target volume coverage and survival - A matched cohort study
Bjohle J; Onjukka E; Rintela N; Eloranta S; Wickman M; Sandelin K; Gagliardi G; Liljegren A
Article: JCO CLINICAL CANCER INFORMATICS. 2018;2:1-13
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study
Biccler JL; Eloranta S; Brown PDN; Frederikseri H; Jerkeman M; Jorgensen J; Jakobsen LH; Smedby KE; Bogsted M; El-Galaly TC
Article: BREAST CANCER RESEARCH. 2018;20(1):142
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725
Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators
Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Bjorkholm M; Lambert PC; Dickman PW; Glimelius I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphomaA population-based study from Sweden
Bjorkholm M; Weibull CE; Eloranta S; Smedby KE; Glimelius I; Dickman PW
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Journal article: RADIOTHERAPY AND ONCOLOGY. 2018;127:s717-s718
EP-1308: Radiotherapy after Immediate Breast Reconstruction with Implant is Safe
Bjöhle J; Onjukka E; Rintelä N; Eloranta S; Wickman M; Sandelin K; Gagliardi G; Liljegren A
Article: BREAST CANCER RESEARCH AND TREATMENT. 2018;168(3):655-666
Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer
Liljegren A; von Wachenfeldt A; Azavedo E; Eloranta S; Grundstrom H; Stahlbom AK; Sundbom A; Sunden P; Svane G; Ulitzsch D; Arver B
Journal article: CANCER MEDICINE. 2018;7(4):1572
Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI (vol 7, pg 114, 2018)
Biccler J; Eloranta S; Brown PDN; Frederiksen H; Jerkeman M; Smedby KE; Bogsted M; El-Galaly TC
Article: RADIOTHERAPY AND ONCOLOGY. 2018;126(3):424-430
Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register
Chen L; Eloranta S; Martling A; Glimelius I; Neovius M; Glimelius B; Smedby KE
Article: ACTA ONCOLOGICA. 2018;57(2):276-282
Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome
Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
Article: BREAST CANCER RESEARCH AND TREATMENT. 2018;167(3):761-769
Safety of fertility preservation in breast cancer patients in a register-based matched cohort study
Rodriguez-Wallberg KA; Eloranta S; Krawiec K; Lissmats A; Bergh J; Liljegren A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):61-68
Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013
Eloranta S; Branvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekstrom-Smedby K
Article: CANCER MEDICINE. 2018;7(1):114-122
Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI
Biccler J; Eloranta S; Brown PDN; Frederiksen H; Jerkeman M; Smedby KE; Bogsted M; El-Galaly TC
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;166(3):887-896
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Frisk G; Tinge B; Ekberg S; Eloranta S; Backlund LM; Lidbrink E; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(10):1159-1167
Parental Age and Risk of Lymphoid Neoplasms
Larfors G; Glimelius I; Eloranta S; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(7):1345-1354
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma
Gordon D; Hansson J; Eloranta S; Gordon M; Gillgren P; Smedby KE
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):230-232
STATIN USE AND PROGNOSIS IN 12,865 NON‐HODGKIN LYMPHOMA PATIENTS TREATED IN THE RITUXIMAB‐ERA
Brånvall E; Eloranta S; Ekberg S; Birmann BM; Smedby KE
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):127-128
LONG‐TERM SURVIVAL AND LOSS IN EXPECTANCY OF LIFE IN A POPULATION‐BASED COHORT OF 7114 PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA
Smedby KE; Ekberg S; Andersson P; Enblad G; Wahlin BE; Hasselblom S; Jerkeman M; Eloranta S
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):100-101
UNMET MEDICAL NEEDS IN HODGKIN LYMPHOMA WITH SPECIAL FOCUS ON THE ELDERLY – a POPULATION‐BASED STUDY OF PATIENTS DIAGNOSED IN SWEDEN 1973‐2014
Bjorkholm M; Weibull CE; Eloranta S; Ekström‐Smedby K; Glimelius I; Dickman PW
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):172-173
MORTALITY RATES REMAIN INCREASED IN YOUNG PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA EVEN AFTER YEARS IN REMISSION: RESULTS FROM A NORDIC LYMPHOMA GROUP STUDY
Biccler J; Glimelius I; Eloranta S; de Nully Brown P; Jakobsen LH; Frederiksen H; Jerkeman M; Bøgsted M
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):179-180
OUTCOME PREDICTION IN DIFFUSE LARGE B‐CELL LYMPHOMA CAN BE GREATLY IMPROVED BY ALTERNATIVE USE OF CLINICAL INFORMATION: A NORDIC LYMPHOMA GROUP STUDY
Biccler JL; Eloranta S; de Nully Brown P; Frederiksen H; Jerkeman M; Smedby KE; Bøgsted M; El‐Galaly TC
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687
Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(3):410-418
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Eskelund CW; Kolstad A; Jerkeman M; Raty R; Laurell A; Eloranta S; Smedby KE; Husby S; Pedersen LB; Andersen NS; Eriksson M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundstrom C; Delabie J; Karjalainen-Lindsberg M-L; Workman CT; Garde C; Elonen E; Brown P; Gronbaek K; Geisler CH
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2016;73(9):627-636
Mortality differences between self-employed and paid employees: a 5-year follow-up study of the working population in Sweden
Toivanen S; Griep RH; Mellner C; Vinberg S; Eloranta S
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2016;25(6):987-994
Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L; Glimelius I; Neovius M; Ekberg S; Martling A; Eloranta S; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344
Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma
Weibull CE; Eloranta S; Smedby KE; Bjorkholm M; Kristinsson SY; Johansson ALV; Dickman PW; Glimelius I
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
Article: BMC CANCER. 2015;15:850
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(10):djv185
Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Sundstrom K; Ploner A; Arnheim-Dahlstrom L; Eloranta S; Palmgren J; Adami H-O; Helm NY; Sparen P; Dillner J
Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432
Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L; Glimelius I; Neovius M; Eloranta S; Ekberg S; Martling A; Smedby KE
Article: MELANOMA RESEARCH. 2015;25(4):348-356
Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study
Gordon D; Gillgren P; Eloranta S; Olsson H; Gordon M; Hansson J; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2015;33(20):2288-2295
Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM-L; Derolf AR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Bjorkholm M
Article: BMC CANCER. 2015;15:412
The loss in expectation of life after colon cancer: a population-based study
Andersson TM-L; Dickman PW; Eloranta S; Sjovall A; Lambe M; Lambert PC
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2014;211(6):681.e1-681.e7
Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study
Joneborg U; Eloranta S; Johansson ALV; Marions L; Weibull CE; Lambe M
Article: INTERNATIONAL JOURNAL OF CANCER. 2014;135(8):1774-1782
Cancer incidence, survival and mortality: Explaining the concepts
Ellis L; Woods LM; Esteve J; Eloranta S; Coleman MP; Rachet B
Article: EPIDEMIOLOGY. 2014;25(5):742-748
The Application of Cure Models in the Presence of Competing Risks A Tool for Improved Risk Communication in Population-Based Cancer Patient Survival
Eloranta S; Lambert PC; Andersson TM-L; Bjorkholm M; Dickman PW
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2014;311(6):597-603
Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparen P; Arnheim-Dahlstrom L
Article: CANCER EPIDEMIOLOGY. 2014;38(1):93-99
Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: A population-based study
Andersson TM-L; Eriksson H; Hansson J; Mansson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Article: PLOS ONE. 2014;9(8):e105279
Temporal Trends in Incidence of Myocardial Infarction and Ischemic Stroke by Socioeconomic Position in Sweden 1987-2010
Malki N; Koupil I; Eloranta S; Weibull CE; Tiikkaja S; Ingelsson E; Sparen P
Article: STATISTICS IN MEDICINE. 2013;32(30):5286-5300
Estimating the loss in expectation of life due to cancer using flexible parametric survival models
Andersson TM-L; Dickman PW; Eloranta S; Lambe M; Lambert PC
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(10):2388-2394
Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer
Sandberg MEC; Alkner S; Hartman M; Eloranta S; Ryden L; Ploner A; Adami H-O; Hall P; Czene K
Article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(11):1435-1441
Temporal Trends in Mortality From Diseases of the Circulatory System After Treatment for Hodgkin Lymphoma: A Population-Based Cohort Study in Sweden (1973 to 2006)
Eloranta S; Lambert PC; Sjoberg J; Andersson TML; Bjorkholm M; Dickman PW
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2013;105(7):469-474
Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
Leval A; Herweijer E; Ploner A; Eloranta S; Simard JF; Dillner J; Young C; Netterlid E; Sparen P; Arnheim-Dahlstrom L
Article: EUROPEAN UROLOGY. 2013;63(4):733-738
Childbearing and the Risk of Bladder Cancer: A Nationwide Population-based Cohort Study
Weibull CE; Eloranta S; Altman D; Johansson ALV; Lambe M
Article: CANCER CAUSES AND CONTROL. 2013;24(3):505-515
How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden
Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM-L; Dickman PW
Article: LAKARTIDNINGEN. 2013;110(8):416-419
[Structuring and documenting research projects].
Eloranta S; Johansson ALV; Kristinsson SY; Andersson TM-L
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(1):60-65
Patterns of survival in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: A population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
Kristinsson SY; Eloranta S; Dickman PW; Andersson TM-L; Turesson I; Landgren O; Bjorkholm M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(24):2995-3001
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Hultcrantz M; Kristinsson SY; Andersson TM-L; Landgren O; Eloranta S; Derolf AR; Dickman PW; Bjorkholm M
Article: BREAST CANCER RESEARCH AND TREATMENT. 2012;134(2):793-800
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
Sandberg MEC; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2012;12:86
Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S; Lambert PC; Andersson TML; Czene K; Hall P; Bjorkholm M; Dickman PW
Article: PLOS ONE. 2012;7(10):e46535
Estrogen Receptor Status in Relation to Risk of Contralateral Breast Cancer-A Population-Based Cohort Study
Sandberg MEC; Hall P; Hartman M; Johansson ALV; Eloranta S; Ploner A; Czene K
Journal article: BLOOD. 2011;118(21):3855
Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005,
Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf ÅR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Björkholm M
Article: ACTA ONCOLOGICA. 2011;50(8):1220-1227
Pancreatic cancer; reporting and long-term survival in Sweden
Lambe M; Eloranta S; Wigertz A; Blomqvist P
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2011;11:96
Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
Andersson TML; Dickman PW; Eloranta S; Lambert PC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18):2514-2520
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
Bjorkholm M; Ohm L; Eloranta S; Derolf A; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Article: ACTA ONCOLOGICA. 2011;50(3):367-372
Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004
Salehi S; Eloranta S; Johansson ALV; Bergstrom M; Lambe M
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2011;173(1):48-54
Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of Non-Hodgkin Lymphoma
Smedby KE; Eloranta S; Duvefelt K; Melbye M; Humphreys K; Hjalgrim H; Chang ET
Journal article: BLOOD. 2010;116(21):205
The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008
Bjorkholm M; Ohm L; Eloranta S; Derolf ÅR; Hultcrantz M; Sjöberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(16):2965-2972
Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000
Eloranta S; Lambert PC; Cavalli-Bjorkman N; Andersson TM-L; Glimelius B; Dickman PW
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;127(8):1923-1930
Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom LA; Ylitalo N; Sundstrom K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami H-O; Sparen P
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2010;19(10):2469-2478
Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
Sundstrom K; Eloranta S; Sparen P; Dahlstrom LA; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami H-O; Ylitalo N
Article: BREAST CANCER RESEARCH AND TREATMENT. 2010;122(3):889-895
Diagnostic work-up of contralateral breast cancers has not improved over calendar period
Sandberg MEC; Hartman M; Edgren G; Eloranta S; Ploner A; Hall P; Czene K
Article: TRANSFUSION. 2010;50(6):1185-1195
Duration of red blood cell storage and survival of transfused patients (CME)
Edgren G; Kamper-Jorgensen M; Eloranta S; Rostgaard K; Custer B; Ullum H; Murphy EL; Busch MP; Reilly M; Melbye M; Hjalgrim H; Nyren O
Article: CANCER CAUSES AND CONTROL. 2010;21(5):759-769
Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sorensen KM; Porwit A; Humphreys K; Melbye M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(6):918-924
Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study
Andersson TM-L; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Bjorkholm M; Dickman PW
Article: HAEMATOLOGICA. 2009;94(12):1714-1720
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
Kristinsson SY; Bjorkholm M; Andersson TM-L; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Journal article: BLOOD. 2009;114(22):1378
Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.
Derolf ÅR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
Article: EPIDEMIOLOGY. 2009;20(5):747-751
Mastitis and the Risk of Breast Cancer
Lambe M; Johansson ALV; Altman D; Eloranta S
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2008;17(9):2344-2349
Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset
Cnattingius S; Eloranta S; Adami H-O; Axelsson O; Dickman PW; Hsieh C-C; Mucci LA; Trichopoulos D; Lambe M; Johansson ALV
Visa fler

Alla övriga publikationer

Letter: ACTA ONCOLOGICA. 2023;62(6):560-564
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
Conference publication: BLOOD. 2022;140:9411-9412
Treatment-Related Circulatory Diseases and Mortality in Hodgkin Lymphoma Patients Using Multi-State Modelling and Relative Survival
Baech J; Jakobsen LH; El-Galaly TCC; Molin D; Glimelius I; Entrop JPP; Crowther M; Smedby KE; Eloranta S; Weibull CE
Conference publication: BLOOD. 2022;140:1079-1081
Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway
Entrop JPP; Weibull CE; Smedby KE; Jakobsen LH; Oevlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fossa A; Smeland KB; El-Galaly TCC; Eloranta S
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):278-295
Predictive models for clinical decision making: Deep dives in practical machine learning
Eloranta S; Boman M
Conference publication: BLOOD. 2021;138:181
High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
Lewis KL; Jakobsen LH; Villa D; Bobillo S; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Caporn PL; Van Zyl J; Klanova M; Trneny M; Puckrin R; Stewart DA; Bishton MJ; Fox CP; Tun AM; Thanarajasingam G; Djebbari F; Joffe E; Eloranta S; Harrysson S; Sehn LH; Maliske SM; Poonsombudlert K; Guo X; Hapgood G; Manos K; Hawkes E; Khwaja J; Minson A; Dickinson M; Ovlisen AK; Gregory GP; Gilbertson M; Streit IT; Scott HW; Ku M; de Mel S; Yong KY; Xin L; Mokoonlall M; Talaulikar D; McVilly NL; Johnston A; Brunner MJ; Pophali PA; Maurer MJ; El-Galaly TC; Cheah CY
Conference publication: BLOOD. 2021;138:454
Risk of Incident Diabetes and Dysregulated Pre-Existing Diabetes Mellitus in Newly Diagnosed Lymphoma Patients Treated with Steroid -Containing Immunochemotherapy: A Danish Population-Based Study
Baech J; Severinsen MT; Ovlisen AK; Frederiksen H; Vestergaard P; Torp-Pedersen C; Jorgensen JM; Clausen MR; Poulsen CB; Brown PDN; Gang AO; Pedersen RS; Smedby KE; Eloranta S; Jakobsen LH; El-Galaly TC
Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28
Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis
Eloranta S; Smedby KE; Dickman PW; Andersson TM
Preprint: ARXIV. 2020
A multi-state model incorporating estimation of excess hazards and multiple time scales
Weibull CE; Lambert PC; Eloranta S; Andersson TML; Dickman PW; Crowther MJ
Conference publication: JOURNAL OF UROLOGY. 2020;203:E247-E248
REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Conference publication: BLOOD. 2019;134:399
Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Hasselblom S; Wahlin BE; Andersson P-O; Smedby KE
Conference publication: BLOOD. 2019;134:4111
Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden
Smedby KEE; Ekberg S; Eloranta S; Enblad G; Jerkeman M; Andersson P-O; Harrysson S
Conference publication: BLOOD. 2019;134:2841
Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients
Ovlisen AK; Jakobsen LH; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Eloranta S; Weibull C; Glimelius I; Smedby KEE; Severinsen MT; El-Galaly TCC
Conference publication: BLOOD. 2019;134:4572
Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group
Glimelius I; Smedby KE; Albertsson-Lindblad A; Eloranta S; Jerkeman M; Weibull C
Letter: INTERNATIONAL JOURNAL OF CANCER. 2019;145(6):1706-1707
Author's reply to: A note on competing risks in analyses of cancer-specific mortality
Benoni H; Smedby KE; Eloranta S
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):e16555
Survival in men diagnosed with castration resistant prostate cancer: A population-based observational study in Sweden.
Aly M; Schain F; Leval A; Liwing J; Lawson J; Vago E; Nordstrom T; Gronberg H; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Preprint: SSRN ELECTRONIC JOURNAL. 2019
Comorbidities and Sex Differences in Causes of Death Among Mantle Cell Lymphoma Patients - A Nationwide Population-Based Cohort Study
Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Conference publication: BLOOD. 2018;132:2975
Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Hasselblom S; Wahlin BE; Andersson P-O; Smedby KE
Conference publication: BLOOD. 2018;132:930
Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients
Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte HJ; Bogsted M; El-Galaly TC; Smedby KE
Conference publication: BLOOD. 2018;132:4200
Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
Smedby KE; Harrysson S; Andersson P-O; Enblad G; Ekberg S; Jerkeman M; Eloranta S
Conference publication: BLOOD. 2018;132:2891
Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study
Glimelius I; Smedby KE; Jerkeman M; Eloranta S; Weibull C
Editorial comment: THE LANCET HAEMATOLOGY. 2018;5(11):e510-e511
Real-world evidence in safety assessment of new treatments
Smedby KE; Eloranta S
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S717-S718
Radiotherapy after Immediate Breast Reconstruction with Implant is Safe
Bjohle J; Onjukka E; Rintela N; Eloranta S; Wickman M; Sandelin K; Gagliardi G; Liljegren A
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):9563
Detailed anatomic site and melanoma prognosis: A population-based study of 6288 patients.
Gordon D; Hansson J; Gordon M; Eloranta S; Gillgren P; Smedby KE
Conference publication: CANCER RESEARCH. 2016;76:p4-11-05-p4-11-05
Safety of fertility preservation indicated by a diagnosis of breast cancer: A Swedish registry-matched cohort study
Rodriguez-Wallberg KA; Eloranta S; Krawiec K; Lissmats A; Liljegren A
Conference publication: GYNECOLOGICAL ENDOCRINOLOGY. 2016;32:77
Safety of fertility preservation indicated by a diagnosis of breast cancer - a Swedish registry-matched cohort study
Rodriguez-Wallberg K; Eloranta S; Krawiec K; Lissmats A; Liljegren A
Conference publication: HAEMATOLOGICA. 2016;101:36
HODGKIN LYMPHOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS-A COMPARATIVE STUDY OF CLINICAL PRESENTATION AND TREATMENT OUTCOME
Englund A; Glimelius I; Rostgaard K; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Smedby KE; Hjalgrim H; Ljungman G; Hjalgrim LL
Conference publication: HAEMATOLOGICA. 2016;101:64-65
HEALTHCARE USE AMONG YOUNG HODGKIN LYMPHOMA SURVIVORS IN THE ERA OF INTENSIFIED CHEMOTHERAPY AND LIMITED RADIOTHERAPY
Eloranta S; Smedby KE; Ekberg S; Chang E; Neovius M; Glimelius I
Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1084
HYDATIDIFORM MOLE AND SUBSEQUENT PREGNANCY OUTCOME: A POPULATION-BASED COHORT STUDY
Joneborg U; Eloranta S; Johansson ALV; Marions L; Weibull CE; Lambe M
Thesis / dissertation: 2013
Development and application of statistical methods for population-based cancer patient survival
Eloranta, Sandra
Letter: EUROPEAN UROLOGY. 2013;64(4):E81
Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the Editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna LV Johansson, Mats Lambe. Childbearing and the Risk of Bladder Cancer: A Nationwide Population-based Cohort Study. Eur Urol 2013;63:733-8
Weibull CE; Eloranta S; Johansson ALV; Altman D; Lambe M
Conference publication: HAEMATOLOGICA. 2013;98:219
TEMPORAL TRENDS IN MORTALITY FROM DISEASES OF THE CIRCULATORY SYSTEM AFTER TREATMENT FOR HODGKIN LYMPHOMA - A POPULATION-BASED COHORT STUDY IN SWEDEN (1973-2006)
Bjorkholm M; Eloranta S; Lambert P; Andersson T; Sjoberg J; Dickman P
Conference publication: BLOOD. 2011;118(21):1648-1649
Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005
Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Bjorkholm M
Conference publication: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2011;173:S230
ESTROGEN RECEPTORS IN CONTRALATERAL BREAST CANCER -EFFECT ON RISK, CORRELATION AND PROGNOSIS
Sandberg MEC; Hartman M; Eloranta S; Ploner A; Hall P; Czene K
Meeting abstract: BLOOD. 2010;116(21):1266-1267
Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008
Hultcrantz M; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Landgren O; Dickman PW; Bjorkholm M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(15):538
An epidemiologic study of the effect of adjuvant radiotherapy on 2D tumor characteristics and prognosis of contralateral breast cancer (CBC).
Sandberg ME; Hartman M; Eloranta S; Ploner A; Hall P; Czene K
Corrigendum: TRANSFUSION. 2010;50(8):1857
Duration of red blood cell concentrate storage and survival of transfused patients. (vol 50, pg 1185, 2010)
Edgren G; Kamper-Jorgensen M; Eloranta S; Rostgaard K; Custer B; Ullman H; Murphy EL; Busch MP; Reilly M; Melbye M; Hjalgrim H; Nyren O
Conference publication: BLOOD. 2010;116(21):93-94
The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008
Bjorkholm M; Ohm L; Eloranta S; Derolf AR; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Conference publication: HAEMATOLOGICA. 2010;95:470
PATTERNS OF SURVIVAL AMONG 7,249 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2003
Hultcrantz L; Kristinsson S; Andersson T; Eloranta S; Derolf A; Landgren O; Dickman P; Bjorkholm M
Conference publication: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;171:S21
EFFECT OF ADJUVANT RADIOTHERAPY ON 2: D TUMOR CHARACTERISTICS AND PROGNOSIS OF CONTRALATERAL BREAST CANCER (CBC)
Sandberg MEC; Hartman M; Eloranta S; Ploner A; Hall P; Czene K
Letter: EPIDEMIOLOGY. 2009;20(5):780-782
Childbearing and Salivary Gland Cancer A Population-based Nested Case-control Study
Lu Y; Lagergren J; Eloranta S; Lambe M
Conference publication: BLOOD. 2009;114(22):561
Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study
Derolf AR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
Conference publication: HAEMATOLOGICA. 2009;94:157
PATTERNS OF SURVIVAL AND CAUSES OF DEATH FOLLOWING A DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED STUDY
Kristinsson SY; Bjorkholm M; Andersson TML; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Conference publication: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2008;167(11):S90
Mastitis and the risk of breast cancer - A population-based study (Sweden)
Lambe M; Johansson A; Altman D; Eloranta S
Scholarly edition:
Estimating and modeling cure within the framework of flexible parametric survival models
Andersson TM-L; Eloranta S; Dickman PW; Lambert PC
Visa fler

Forskningsbidrag

Eloranta, Sandra Maria – Survivorship after aggressive lymphoma in the era of intensive immunochemotherapy
Swedish Cancer Society
1 January 2023
Överlevarskap efter intensiv cytostatistikabehandling för aggressiv lymfomsjukdomar
Cancerfonden
1 January 2023 - 31 December 2025
Real-world outcomes in lymphoma and long-term benefit/risk balance of available therapies - A Nordic, multidisciplinary research program
Nordisk cancerunion
1 January 2022 - 31 December 2024
Childbearing after modern-day intensive chemotherapy in young Hodgkin and non-Hodgkin lymphoma survivors
Swedish Cancer Society
1 January 2020
Childbearing after modern-day intensive chemotherapy in young Hodgkin and non-Hodgkin lymphoma survivors
Swedish Cancer Society
1 January 2019

Anställningar

Senior Forskare, Medicin, Solna, Karolinska Institutet, 2022-

Examina och utbildning

Docent, Klinisk epidemiologi, Karolinska Institutet, 2020
Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2013

Uppdrag

Projektledare, Implementationsprojektet för Clinicum, Institutionen för medicin Solna, Karolinska institutet, 2023-
Forskargruppsledare, Team Sandra Eloranta, Institutionen för Medicin, Solna, Karolinska institutet, 2022-

Handledare

Ida Hed Myrberg, 2023
Ida Hed Myrberg, 2023
Joshua Entrop, Childbearing after modern-day intensive immunochemotherapy in young Hodgkin and non-Hodgkin lymphoma survivors, https://ki.se/en/people/joshua-entrop, 2020
Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, https://openarchive.ki.se/xmlui/handle/10616/46467, 2014
Joelsson Joel, Second malignancies after non-Hodgkin lymphoma diagnosis and early identification of patients with poor outcomes

Nyheter från KI

Kalenderhändelser från KI